Arca
Skip to content
Tools
Tools

MammoScreen® (5)

Radiological Computer Assisted Detection/Diagnosis Software For Lesions Suspicious For Cancer. 510(k) K260714, from Therapixel (Nice, FR). Product code QDQ, class 2.

As of Nov 18, 2026, K260714 is an FDA 510(k) held by Therapixel, substantially equivalent on Jun 26, 2026 after 113 days, with no recalls tied to it in FDA's recall database.

  • Review time: 113 days
  • Recalls: 0

Predicate devices

The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF

Other QDQ clearances

The newest 510(k)s for the same product code; their median review was 159 days; see every QDQ device

Elsewhere

Record

Type
Special
Received
Mar 5, 2026
Review panel
Radiology
Regulation
21 CFR 892.2090

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.